Progesterone for menopause · Put the whole plan in view
Checked 2026-09-27CoreAge Rx: oral progesterone product and service

Provider product page

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-10-13Midi: hormone replacement therapy, visits and coverage

Provider service and payment terms

Open the source →

Checked 2026-10-13. Documents, terms and product availability can change.

Checked 2026-09-27Midi: micronized progesterone discussion, July 2, 2026

Provider treatment discussion

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27Evernow: progesterone treatment page and product FAQ

Provider treatment page; full public HTML checked

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27Evernow: how membership and pay-per-visit care work

Provider service terms

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27Evernow: care, insurance, membership and pharmacy FAQ

Provider service and payment terms

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27Evernow: hormone therapy and separate medication costs

Provider treatment page; full public HTML checked

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27FDA: current hormone therapy categories and warning changes

Federal regulator patient information

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-10-21FDA: first six menopausal hormone therapy label revisions, February 12, 2026

Federal regulator announcement

Open the source →

Checked 2026-10-21. Documents, terms and product availability can change.

Checked 2026-09-27ACOG: Hormone Therapy for Menopause

Medical society patient guidance

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27ACOG: Perimenopausal Bleeding and Bleeding After Menopause

Medical society patient guidance

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27FDA: Understanding the Risks of Compounded Drugs

Federal regulator compounding explanation

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-10-21DailyMed: current Acertis Prometrium progesterone capsule record, updated July 23, 2026

Exact prescription product labeling

Open the source →

Checked 2026-10-21. Documents, terms and product availability can change.

Checked 2026-09-27Pfizer: Provera medroxyprogesterone acetate tablet labeling

Exact prescription product labeling; used for ingredient identity

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27ACOG: Hysterectomy

Specialty society surgery terminology and patient guidance

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27British Menopause Society: Progestogens and Endometrial Protection, May 2026

UK specialty clinical guidance; evidence limits, not US product approval

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27British Menopause Society: Induced Menopause in Women with Endometriosis, February 2026

UK specialty clinical guidance; limited evidence and individualized discussion

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27Pfizer: Estring estradiol vaginal system prescribing information, revised April 2026

Current manufacturer prescribing label

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27DailyMed: Femring estradiol acetate vaginal ring, record updated December 9, 2025

Exact product label; prescribing information revised November 2023

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27North American Menopause Society: 2020 Genitourinary Syndrome of Menopause Position Statement

Published specialty consensus abstract; reviewed at abstract level

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27AUA/SUFU/AUGS: Genitourinary Syndrome of Menopause Guideline, 2025

Multisociety clinical guideline

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27DailyMed: Duavee conjugated estrogens and bazedoxifene tablets, record updated July 31, 2026

Exact combination-product labeling; PI revised March 2024

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-09-27ACOG: Abnormal Uterine Bleeding

Specialty society patient guidance; reviewed August 2025

Open the source →

Checked 2026-09-27. Documents, terms and product availability can change.

Checked 2026-10-13Alloy: hormone replacement therapy

Provider clinical offer and one-time consultation fee; treatment categories not a personal recommendation

Open the source →

Checked 2026-10-13. Documents, terms and product availability can change.

Checked 2026-10-13Alloy: progesterone pill offer

Provider product record; approval wording attributed, one-month price versus three-month supply unresolved; no manufacturer or supplied label confirmed

Open the source →

Checked 2026-10-13. Documents, terms and product availability can change.

Checked 2026-09-29FDA: Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms

Current federal categories and product-specific warning-change context; systemic estrogen and topical vaginal therapy distinguished, no class-wide warning conclusion

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29North American Menopause Society: 2020 Genitourinary Syndrome of Menopause position statement

Published professional consensus abstract only; low-dose vaginal therapy distinction, lack of endometrial trials beyond one year and breast-cancer evidence limits

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29ACOG: Hysterectomy

US specialty patient guidance; uterus, cervix and ovary procedures distinguished, no treatment decision from surgery name alone

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-28Alloy: terms of use

Dated platform terms; subscription and shipment cancellation deadlines, first-shipment refund conditions and service-fee exclusions kept separate

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-29ACOG: Perimenopausal Bleeding and Bleeding After Menopause

US specialty patient guidance reviewed February 2024; bleeding changes require professional assessment, not a site-generated workup or medication adjustment

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Winona: Progesterone Capsules

Provider oral-product listing; peanut oil and gelatin declared, starting price and broad cream-equivalence claims separated, no actual manufacturer or shipment authenticated

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Winona: Estrogen Body Cream with Progesterone

Provider compounded estradiol/estriol/progesterone cream and starting price; uterine-protection and safety language attributed, not independently demonstrated

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29British Menopause Society: Progestogens and Endometrial Protection (reviewed February 2026)

UK professional guidance internally reviewed February 2026, May 2026 file version; compounded transdermal progesterone evidence and absorption limitations, no claim of testing a reviewed brand

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Winona: Frequently Asked Questions

Provider clinical and subscription conditions; age 35–59, listed jurisdictions, asynchronous care, differing approval descriptions, 28/84-day processing and 24-hour order window

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29FDA: Understanding the Risks of Compounded Drugs

Federal regulatory explanation; compounded preparations are not FDA-approved, no inference about inspection or quality of a named pharmacy

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Gennev: virtual menopause care

Provider physician and dietitian service; actual relevant prescribing, but no exact oral progesterone product or capsule formulary established

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29ACOG: Hormone Therapy for Menopause

US specialty patient guidance; systemic and local exposure, treatment goals and clinical assessment, no personal regimen

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-28Gennev: insurance and pricing

Dated provider fee table and coverage process; doctor/dietitian initial/follow-up costs are separate from pharmacy charges

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-29MyMenopauseRx: treatments

Provider catalog naming progesterone and collective dosage forms; no inference that every hormone comes in every listed form

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-28MyMenopauseRx: telehealth FAQ

Dated provider visit/pharmacy/refill/coverage/cancellation record; personal prescription, generic identity and clinical decisions remain unverified

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-29Pandia Health: menopause hormone therapy

Provider therapy and capsule catalog; names progesterone and Prometrium, no selected stock or equivalence inference; public regimens not transferred

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-28Pandia Health: menopause care and delivery

Dated provider plans and prescription-transfer offer; separate medicine cost, billing units, 30-day notice and possible early fee, malformed three-month currency and inconsistent savings retained

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-29Stella: US virtual menopause clinic

US provider clinical service and example plans; examples do not establish a universal oral preparation or individual outcome

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-28Stella US: frequently asked questions

Dated US provider age range, visit fees, pharmacy and coaching scope; no exact capsule ingredients, guaranteed reimbursement or UK offer inferred

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-28Wisp: menopause consultation

Dated provider offer naming micronized progesterone and other oral options; starting care charge excludes local-pharmacy medicine, eligibility FAQ extraction incomplete

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-28Wisp: terms of use

Dated platform transaction terms; prescription renewal review, 48-hour cancellation and discretionary product remedies; not individual legal advice

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-29Joi + Blokes: hormone care and progesterone listings

Provider capsule versus cream, separate quarterly charges, compounding notice and promotional claims; exact capsule identity, first-lab total and cancellation wording unresolved

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29FDA: Menopause

Current federal patient guidance; product-dependent benefits/risks and prevention limits, no personal eligibility or class-wide label-change inference

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29British Menopause Society: Induced Menopause in Women with Endometriosis, February 2026

UK professional guidance; specific endometriosis-related exception and limited high-quality evidence, not US approval or individual instructions

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-28Joi + Blokes: separate HRT offer

Dated distinct offer with different lab promotion and local-pharmacy prescription fee; not silently merged into all current orders

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-28Joi + Blokes: service and coach roles

Dated provider homepage; coach role expressly excludes diagnosis/prescribing/specific medical advice; no individual service result verified

Open the source →

Checked 2026-09-28. Documents, terms and product availability can change.

Checked 2026-09-29Thrivelab: Menopause hormone care

Provider clinical-service description; treatment and access wording is not an individual prescribing or state-eligibility confirmation

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Thrivelab: Medication prices

Provider medication tables dated April 5, 2024 and February 19, 2025; current page access does not update historical prices or explain formulation codes

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Thrivelab: Frequently asked questions

Provider FAQ; separate membership, medication, state-access, laboratory and refund descriptions retain their stated limits

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Defy Medical: Menopause care

Provider menopause consultation and follow-up offer; no confirmed individual medicine, outcome or availability

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Defy Medical: Hormone therapy

Provider treatment and route menu; oral hormone capsules do not establish a named progesterone formulation

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29ACOG: Hormone Therapy for Menopause

US professional patient guidance, last updated October 2021 and reviewed February 2024; treatment categories and reassessment, not individual prescribing or a provider protocol

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29ACOG: Hysterectomy

US professional patient guidance, updated September 2024 and reviewed May 2025; distinguishes operative terms without inferring an individual operation or hormone need

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29NAMS: The 2020 genitourinary syndrome of menopause position statement — abstract

Published professional consensus abstract only; low-dose vaginal estrogen distinction retains absent endometrial-safety clinical trials beyond one year, not a complete-paper or individualized assessment

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Defy Medical: How much does BHRT cost?

Provider illustrative monthly cost averages, not fixed monthly billing or a capsule quote

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29NHS: Postmenopausal bleeding

UK public patient guidance, reviewed September 24, 2026; bleeding assessment advice does not diagnose a cause or transfer NHS referral timings to US services

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29BodyLogicMD: Menopause

Provider menopause service and attributed testing or outcome claims; not comparative clinical evidence

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29British Menopause Society: Progestogens and endometrial protection

UK professional clinical tool, internally reviewed February 2026; May 2026 is the URL/file version, not the stated review month. Preparation-specific evidence and endometrial-protection limits, with no dose or schedule instructions reproduced

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29BodyLogicMD: Find a bioidentical hormone doctor

Provider network and access description; no individual provider availability or exact capsule confirmed

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29BodyLogicMD: Pricing

Provider membership and member-pricing terms; membership does not include every test or treatment

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Renew Youth: Menopause services

Provider menopause clinical program and entry laboratory offer; exact capsule and complete treatment cost unconfirmed

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Renew Youth: The Calming Hormone Women Need

Provider article dated March 24, 2026; broad benefit and no-side-effect statements are attributed and critically qualified, not endorsed

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29FDA: Menopause

Federal patient information; clinical assessment, hormone-treatment risks and limits of bioidentical safety claims

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29FDA: Understanding the Risks of Compounded Drugs

Federal primary guidance on compounding and lack of FDA premarket approval; not individual treatment advice

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29British Menopause Society: Induced menopause in women with endometriosis, February 2026

UK professional clinical tool, February 2026; post-hysterectomy exceptions depend on residual disease and individual risks, with limited high-quality evidence and case-by-case decisions

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Hone Health: Premium Membership, Full Clinical Insight for Women

Provider Premium membership, separate estimated medicine menu and purchase conditions; compounded oral capsule listing is not an approved-product identity

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Hone Health: Menopause treatment

Provider menopause service, treatment goals and promotional timeline; not an individual outcome prediction

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Hone Health: Progesterone Capsule for Women, Risks and Benefits

Provider capsule benefit claims, including an unqualified cancer-prevention statement; reviewed as marketing and limited with exact FDA label context

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29FDA: Prometrium progesterone capsules prescribing information

Exact FDA product label, reference ID 5744934; ingredients, indications and warnings apply to this product, not all progesterone preparations

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Lifeforce: Micronized Progesterone

Provider product description, soy/peanut allergy notice and access terms; exact oral capsule, manufacturer and complete excipients not established

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Lifeforce: Menopause Management

Provider menopause service and plan descriptions; different membership and testing statements remain unreconciled

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Lifeforce: Become a member

Provider recurring membership services and support roles; not a personal testing schedule or capsule price

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Fountain: Hormone therapy for women

Provider clinical service and kit; full four-, twelve- and forty-eight-week billing periods retained, exact capsule unconfirmed

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Fountain: Terms and conditions

Provider terms dated April 3, 2024; medical-group, prescription and pharmacy-choice clauses, not individual coverage or refund confirmation

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Alpha Hormones: Bioidentical hormone replacement therapy

Provider treatment menu naming FDA-approved oral micronized progesterone and separately compounded options; no exact prescribed product confirmed

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Alpha Hormones: Pricing

Provider program starting prices, setup fee, access and insurance descriptions; individual selection and benefits remain unverified

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Alpha Hormones: Subscription cancellation policy

Provider recurring billing, refill-request and cancellation/return conditions; attributed purchase policy, not generalized legal advice

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Newson Clinic: Consultations

UK clinical assessment service; no exact oral medicine, individual eligibility or later NHS prescribing agreement confirmed

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Newson Clinic: Menopause care and appointment prices

UK provider service, locations and clinician-specific initial/follow-up price cards; appointment fees are not medicine prices

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Newson Clinic: Prices

UK provider price-page access record; full fee table absent from returned text, so numeric appointment fees use the separately cited service-page cards

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29NICE NG23: Menopause, identification and management — recommendations

UK clinical recommendations; systemic/local exposure, total hysterectomy and specialist-history qualifications are not provider-specific protocol or personal treatment directions

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Myla Health: Our services

UK provider consultation, written-summary and paid follow-up pathway; published arrangements are not tested service or response guarantees

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Myla Health: Frequently asked questions

UK provider clinical, geographic, records-review, pharmacy, NHS handoff and follow-up conditions; no individual eligibility or later GP agreement inferred

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Myla Health: Pricing

UK provider prices effective April 1, 2026; consultation, prescription administration and separate pharmacy medicine costs retain their published units

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Duke Health — Menopause Treatment

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Duke Women’s Health Associates at Patterson Place

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Cleveland Clinic — Menopause Treatment

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Cleveland Clinic — Specialized Women’s Health and Menopause

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Mayo Clinic — Menopause and Women’s Sexual Health Clinic in Minnesota

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Mayo Clinic — Women’s Health Specialty Clinic in Florida

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Johns Hopkins Medicine — Center for Menopause and Midlife Health

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Johns Hopkins Medicine — Menopause Clinic

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Mount Sinai — Menopause Care and Treatments

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Mount Sinai — Menopause Treatment Locations

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Northwestern Medicine — Program for Menopause

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Northwestern Medicine — Center for Sexual Medicine and Menopause, Chicago

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29UCLA Health — Comprehensive Menopause Program: Clinical Services

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29UCLA Health — Comprehensive Menopause Program: Patient Information

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Stanford Health Care — Menopause

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Stanford Health Care — Menopause Treatments

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29University of Utah Health — Midlife Women’s Health and Menopause Program

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29University of Utah Health — What to Expect at Your Midlife Appointment

Official regional health-system clinical service, appointment or location information; individual medicine, access and full cost remain unconfirmed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29The Menopause Society — Hormone Therapy

Professional patient education distinguishing systemic and low-dose vaginal estrogen; not an individual decision rule or provider protocol.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29NICE NG23 — Menopause: identification and management, Recommendations

UK professional clinical guideline; breast-cancer history and other stated conditions retain their specific scope, uncertainties and specialist context.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29NICE NG23 — Rationale and impact

UK guideline rationale; subtotal hysterectomy and conditions leading to surgery need individualized consideration. Does not establish any US institution’s protocol.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29Mayo Clinic — Menopause hormone therapy: Does it cause vaginal bleeding?

Clinical patient explanation dated November 26, 2025; possible causes require professional assessment, with no personal diagnosis or waiting interval inferred.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29ACOG — Hormone Therapy for Menopause

Professional patient FAQ, last reviewed February 2024; clinical context only, not a provider protocol or all-product current-label summary.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-09-29FDA — Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms

Federal primary description of hormone-therapy categories and product-specific labeling changes; no claim that all warnings were removed.

Open the source →

Checked 2026-09-29. Documents, terms and product availability can change.

Checked 2026-10-12CoreAge Rx: shipping reference and service details

Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test

Open the source →

Checked 2026-10-12. Documents, terms and product availability can change.

Checked 2026-10-13Midi: custom compounded progesterone product

Provider product offer; out-of-pocket price, composition and Arizona restriction

Open the source →

Checked 2026-10-13. Documents, terms and product availability can change.

Checked 2026-10-13Midi: current visit prices and insurance rules

Provider commercial terms; individual benefits unverified

Open the source →

Checked 2026-10-13. Documents, terms and product availability can change.

Checked 2026-10-21Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.

Indexed primary study abstract

Open the source →

Checked 2026-10-21. Documents, terms and product availability can change.

Checked 2026-10-21Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial.

Indexed primary study abstract and full research article

Open the source →

Checked 2026-10-21. Documents, terms and product availability can change.

Checked 2026-11-13PROMETRIUM: February 2026 label revision; DailyMed record updated July 23, 2026

U.S. product label

Open the source →

Checked 2026-11-13. Documents, terms and product availability can change.

Checked 2026-11-13ACOG: Hysterectomy; updated and reviewed October 2026

U.S. patient guidance

Open the source →

Checked 2026-11-13. Documents, terms and product availability can change.

Checked 2026-11-13BMS: Progestogens and endometrial protection; May 2026 file, reviewed February 2026

UK professional guidance

Open the source →

Checked 2026-11-13. Documents, terms and product availability can change.

Checked 2026-11-13Femring: November 2023 label revision; DailyMed record updated October 29, 2026

U.S. product label

Open the source →

Checked 2026-11-13. Documents, terms and product availability can change.